Delivery Order 75N91019D00030-75N91019F00129

Award Date 8/31/19
Potential Completion Date 8/30/20
Potential Value $2.7K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Plainfield, NJ 07080, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Genewiz, LLC, a global contract research organization specializing in genomic services. The $37,046.85 contract is for gene synthesis, custom cloning, and variant synthesis. Genewiz has provided DNA and RNA sequencing, bioinformatics, and other genomic services to federal agencies such as the NIH, NCI, VA, and USGS...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $60,000 firm fixed price delivery order to Genewiz, LLC of South Plainfield, New Jersey on June 1, 2022. The delivery order, which does not have a set-aside designation and is to be completed by November 30, 2022, is likely in support of genomic or biological services. Genewiz, LLC is a subsidiary of Azenta, Inc., which does business as Brooks, a global provider...
This is a $108,000.00 firm fixed price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Genewiz, LLC, a subsidiary of Azenta, Inc. The contract is for 12 months of funding and does not have a set-aside designation. Genewiz provides genomic services such as gene synthesis, next generation sequencing, Sanger sequencing, and bioinformatics to support research initiatives at various federal agencies including NIEHS, the National...
Genewiz, LLC was awarded a $90,000 firm fixed price delivery order against contract number 75N96020D00001 to provide services to the National Institute of Environmental Health Sciences, part of the Department of Health and Human Services National Institutes of Health, for the period of December 1, 2022 through September 30, 2023. The work will be performed in South Plainfield, New Jersey and no set-aside designation was used for this award. Genewiz, LLC is a subsidiary of Azenta, Inc., which...
This federal contract award to Genewiz, LLC, a global contract research organization, is for SEQUENCING SERVICE with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $93,600.00 firm fixed price contract was awarded on a sole source basis under FAR 6.302-1 due to Genewiz's unique capabilities to meet the salient requirements of the research trial. The contract was not set aside and is part of Genewiz's existing federal...
This federal contract award to Genewiz, LLC, a global contract research organization, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $5,300.00 firm fixed price purchase order is for other functions - whole genome sequencing of 8 samples. The award has no set-aside designation. Through this contract, Genewiz will provide specialized genomic services, including next-generation sequencing, to support research...
Genewiz LLC was awarded a firm fixed price purchase order valued at twenty thousand, six hundred eighty-nine dollars and seventy cents ($20,689.70) by the Department of Health and Human Services National Institutes of Health National Institute of Nursing Research. The contract has no set-aside designation. Genewiz LLC, a subsidiary of Azenta, Inc. doing business as Brooks, will deliver unspecified products or services to the agency by July 26, 2019 at its location in South Plainfield, New...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Genewiz, LLC, a for-profit global contract research organization specializing in genomic services. The 1-year, $25,034 purchase order tasked Genewiz with providing DNA sequencing services as needed from November 1, 2010 through October 31, 2011. This work was performed directly for the NIDDK and was not associated with any set-aside designation. Genewiz...
The National Cancer Institute awarded a $2.1 million delivery order to the New York Genome Center, Inc., doing business as Nygc, against the NCI Genomic Characterization Centers master IDIQ contract. This task order, with a period of performance from August 2019 through August 2020, supports NCI's Center for Cancer Genomics program through genomic characterization services. As the prime contractor, Nygc will leverage its expertise in genomic analysis to further the NIH's mission of understanding...
The National Institutes of Health National Institute of Environmental Health Sciences awarded a $42,000 firm fixed price delivery order contract to Genewiz, LLC for DNA sequencing services. Under the contract, Genewiz will provide sequencing support to further the NIH NIEHS's research efforts in understanding the effects of environmental influences on human health and disease. The contract was awarded on November 27, 2019 and has a period of performance through November 26, 2024. No set-aside...

Genewiz, LLC has been awarded a $2,675 delivery order against the National Cancer Institute's Genomic Characterization Centers indefinite-delivery/indefinite-quantity master contract. The delivery order is for genomic characterization services to support the National Cancer Institute's Genomic Characterization Center program. The National Institutes of Health's National Cancer Institute will provide funding. Performance will take place in South Plainfield, New Jersey over a one year period concluding in August 2020. The contract has a firm fixed price structure and no set aside designation. Genewiz will serve as the prime contractor to deliver genomic analysis and related services that further the National Cancer Institute's efforts to integrate genomic data into cancer research and clinical care.

Generated 12/31/23, 3:01 AM